Specific immunotherapy modifies allergen-specific CD4(+) T-cell responses in an epitope-dependent manner

Area of Science:

• Immunology
• Allergy Research
• Vaccine Development

Background:

• Understanding immune responses at the T-cell epitope level is crucial for developing effective allergy vaccine strategies.
• Allergic inflammation involves complex T-cell mechanisms that need further elucidation.

Purpose of the Study:

• To characterize allergen-specific T-cell responses in individuals with allergy and those with peripheral tolerance.
• To investigate changes in CD4(+) T-cell responses to specific epitopes during allergen-specific immunotherapy.

Main Methods:

• Timothy grass pollen (TGP) allergy served as a model system.
• Ex vivo peptide-MHC class II tetramer approach was used to analyze T-cell responses.
• Responses were assessed in allergic, nonatopic, and immunotherapy-treated subjects.

Main Results:

• Allergic individuals exhibit CD4(+) T-cell responses to a wide array of TGP epitopes with distinct immunodominance hierarchies.
• Specific epitopes were identified as driving either TH2 or TH1/TR1 responses.
• Allergen-specific immunotherapy led to a preferential decrease in allergen-specific TH2 cells, with no significant change in TH1/TR1 cells.

Conclusions:

• Preferential deletion of allergen-specific TH2 cells is a significant mechanism for restoring tolerance during immunotherapy.
• This finding offers insights into the immunological shifts occurring during successful allergy treatment.